University of Miami
Anti-C5 Complement Therapy in NMO: Eculizumab and Ravulizumab
By
University of Miami
FEATURING
Flavia Nelson
By
University of Miami
FEATURING
Flavia Nelson
Login to view comments.
Click here to Login